A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19

by Michael A. Puskarich, Nathan W. Cummins, Nicholas E. Ingraham, David A. Wacker, Ronald A. Reilkoff, Brian E Driver, Michelle H. Biros, Fernanda Bellolio, Jeffrey G. Chipman, Andrew C. Nelson, Kenneth Beckman, Ryan Langlois, Tyler Bold, Matthew T. Aliota, Timothy W. Schacker, Helen T. Voelker, Thomas A Murray, Joseph S. Koopmeiners, Christopher J. Tignanelli
Published 2021-07-01